Skip to content

Adropin Levels in Periodontal Disease

Adropin Levels in GCF and Serum of Periodontitis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07695857
Enrollment
60
Registered
2026-07-10
Start date
2018-04-02
Completion date
2020-11-06
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

periodontitis, Adropin, gingival crevicular fluid, serum

Brief summary

This study aimed to evaluate gingival crevicular fluid (GCF) and serum levels of Adropin and tumor necrosis factor (TNF)-alfa in patients with periodontitis before and after non-surgical periodontal therapy.

Detailed description

Thirty periodontitis and thirty periodontally healthy individuals were enrolled in the study. Clinical periodontal measurements were recorded; periodontitis patients received non-surgical periodontal treatment, and GCF and serum samples were collected at baseline and at 6 weeks after treatment. Adropin and TNF-alfa were determined by ELISA.

Interventions

Nonsurgical periodontal therapy includes oral hygiene education and scaling and root planning approaches to eliminate microbial dental biofilm that is the primary etiology of periodontal diseases.

Sponsors

Giresun University
Lead SponsorOTHER
Aydin Adnan Menderes University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
27 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* having at least 20 natural teeth, excluding third molars * having no systemic disease * non-smokers * Diagnosed with periodontally health and periodontitis patients

Exclusion criteria

* having any systemic diseases * smoking * current pregnancy or lactation * a history of periodontal treatment in the past 6 months * using antibiotic, anti-inflammatory drugs or any other drugs within the past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
1. Adropin levelsBaseline and at 6 weeks after therapyChanges in Adropin levels before and after periodontal therapy

Secondary

MeasureTime frameDescription
TNF-alfa levelsbaseline and at 6 weeks after therapyChanges in TNF-alfa levels before and after periodontal therapy

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026